JPH05237180A - Bone joining device - Google Patents

Bone joining device

Info

Publication number
JPH05237180A
JPH05237180A JP4079003A JP7900392A JPH05237180A JP H05237180 A JPH05237180 A JP H05237180A JP 4079003 A JP4079003 A JP 4079003A JP 7900392 A JP7900392 A JP 7900392A JP H05237180 A JPH05237180 A JP H05237180A
Authority
JP
Japan
Prior art keywords
core material
plla
polylactic acid
bone
pla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4079003A
Other languages
Japanese (ja)
Other versions
JP3010279B2 (en
Inventor
Yasuo Shikinami
保夫 敷波
Kunihiro Hata
邦広 畑
Hidekazu Bouya
英和 棒谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takiron Co Ltd
Original Assignee
Takiron Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takiron Co Ltd filed Critical Takiron Co Ltd
Priority to JP4079003A priority Critical patent/JP3010279B2/en
Publication of JPH05237180A publication Critical patent/JPH05237180A/en
Application granted granted Critical
Publication of JP3010279B2 publication Critical patent/JP3010279B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive

Landscapes

  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)

Abstract

PURPOSE:To provide the bone joining device which has excellent initial strength and initial modulus of elasticity and with which the part coated with polylactic acid is absorbed in about several months after implantation into a living body, the probability of inducing an inflammation is extremely low, the cavity after absorption by the neobone is filled in an early period and the core material adapts itself to the biotissue, thereby the re-operation to draw out a mail is no need. CONSTITUTION:This bone joining material is constituted by using a molding of biode gradable polymer contg. 75 to 95wt.% respective independent materials of hydroxy apatite (HA), tricalcium phosphate (TC) and crystallized glass contg. HA and wallastonite or the mixture composed thereof as a core material and coating this core material with the polylactic acid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、骨の損傷や骨折時ある
いは骨移植時に、骨が形成されるまでその部分を固定
し、補助及び補綴する骨接合用デバイスに関する。更に
詳しくは、芯材として生体骨と同等の組成又はバイオア
クティブなセラミックスを有する成分に生分解性ポリマ
ーを加えた成形体を使用し、これを生体内分解吸収性の
ポリ乳酸で被覆した骨接合用デバイスに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an osteosynthesis device for fixing and assisting and prolonging bone parts during bone damage, fracture or bone transplantation. More specifically, as a core material, a molded body obtained by adding a biodegradable polymer to a component having a composition equivalent to that of living bone or bioactive ceramics is used, and this is coated with biodegradable and absorbable polylactic acid. For devices.

【0002】[0002]

【従来の技術】整形外科、形成外科、胸部外科、口腔外
科等の外科分野では、生体骨の固定、接合を目的とした
人工整復材として、従来より金属製(Cr−Ni合金
系、Ti合金系など)とセラミックス製(アルミナ、ジ
ルコニアなどの酸化物系セラミックスや、ハイドロキシ
アパタイト、燐酸三カルシウムなどの燐酸カルシウム系
セラミックスなど)の無機材料が使用されるようになっ
ている。
In the field of surgery such as orthopedic surgery, plastic surgery, thoracic surgery and oral surgery, it has been conventionally used as an artificial reduction material for fixing and joining biological bones (Cr-Ni alloy type, Ti alloy type). Etc.) and ceramics (oxide ceramics such as alumina and zirconia, and calcium phosphate ceramics such as hydroxyapatite and tricalcium phosphate) have been used.

【0003】また最近では、ポリ乳酸、ポリグリコール
酸、ポリジオキサノン或はこれらの共重合体からなる生
体内分解吸収性材料を用いた整復材に関する研究も盛ん
で、臨床試験の段階を経て実用化されつつある。
[0003] Recently, research on a reduction material using a biodegradable and absorbable material composed of polylactic acid, polyglycolic acid, polydioxanone or a copolymer thereof has been actively conducted, and put into practical use after the stage of clinical trials. It's starting.

【0004】[0004]

【発明が解決しようとする課題】上記の金属製材料は長
期の実績があり、よく用いられているが、弾性率が非常
に高いため周囲骨の強度を低下させたり、また金属イオ
ンの溶出によって生体を損傷する可能性があるなどの問
題点を有している。更に、金属製材料の最大の欠点は、
骨折や骨の損傷が治癒した時点で、それを生体内から取
り出すために再手術をしなければならず、そのことが患
者に肉体的、経済的な負担を強いる点にある。
The above-mentioned metallic materials have a long-term track record and are often used. However, due to their extremely high elastic modulus, the strength of the surrounding bone is reduced, and the elution of metal ions causes It has a problem that it may damage the living body. Furthermore, the biggest drawback of metallic materials is
When a fracture or bone damage is healed, it must be re-operated to remove it from the living body, which imposes a physical and economic burden on the patient.

【0005】一方、セラミックス製材料は、生体適合性
が良好なことから、近年盛んに試用されているが、これ
らもまた金属製材料と同様に弾性率が高いことに起因す
る弊害を問題点として残している。また、セラミックス
製材料は他の材料と比較して脆いという点にも問題があ
る。
On the other hand, ceramic materials have been actively used in recent years because of their good biocompatibility. However, these materials also have the problem of having a high elastic modulus like metal materials. I have left. Another problem is that ceramic materials are more brittle than other materials.

【0006】このような骨接合用デバイスとして、近
年、生体吸収性高分子を用いる研究が盛んであり、特に
ポリ乳酸、ポリグリコール酸、グリコール酸−乳酸コポ
リマーを成形することにより骨接合用デバイスを得ると
いう研究が多く、特開昭59−97654号、特開平1
−198552号、特開平1−198553号、特開平
3−29663号、特開平3−103429号などはそ
の例である。なかでも、本発明者らは、特開平1−19
8553号において、粘度平均分子量が30万以上のポ
リ乳酸を成形し、その後延伸操作を加えることにより、
初期強度及び初期弾性率が生体骨と同程度で、且つ骨折
及び損傷を受けた骨の強度と機能がほぼ回復するまでの
間、生体骨に近い強度を維持しており、最終的に骨の形
成が完了する頃には、生体内に完全に吸収されていくと
いう理想的な骨接合材を提供した。更に本発明者らは、
特開平3−29663号において、生体の各部位におけ
る骨の必要強度と強度保持期間を明確にし、各部位に好
適に使用される骨接合材を提供した。
As such an osteosynthesis device, researches using a bioabsorbable polymer have been actively conducted in recent years, and in particular, the osteosynthesis device is formed by molding polylactic acid, polyglycolic acid, or glycolic acid-lactic acid copolymer. There are many researches to obtain the method, and the methods are disclosed in JP-A-59-97654 and JP-A-1.
Examples thereof include JP-A-198552, JP-A-1-198553, JP-A-3-29663, and JP-A-3-103429. Among them, the present inventors have disclosed in Japanese Patent Application Laid-Open No. 1-19
No. 8553, polylactic acid having a viscosity average molecular weight of 300,000 or more is molded, and then stretched,
The initial strength and elastic modulus are similar to those of living bones, and the strength and function of the bones that have been fractured or injured are almost restored until the strength and function of the bones are almost restored. By the time the formation was completed, it provided an ideal bone cement that would be completely absorbed in the living body. Furthermore, the present inventors
In Japanese Patent Laid-Open No. 3-29663, the required strength and strength retention period of the bone in each part of the living body are clarified, and a bone bonding material suitable for use in each part is provided.

【0007】本発明者らが提供したこれらの骨接合材
は、強度的には骨接合材として要求される特性を全て満
たしており、現在に至っても問題のない優れた材料であ
る。しかし、一方で、ポリ乳酸からなる径の太いスクリ
ュー等を用いた場合には、その吸収速度がスローであ
り、完全に吸収されるまでに1年半〜3年、場合によっ
ては3年以上かかるものがあることが判ってきた。
These bone-bonding materials provided by the present inventors satisfy all the properties required as a bone-bonding material in terms of strength, and are excellent materials that have no problems even now. However, on the other hand, when a large diameter screw made of polylactic acid or the like is used, its absorption rate is slow, and it takes one and a half to three years, and sometimes three years or more to be completely absorbed. It turns out that there is something.

【0008】また、生体吸収性材料を用いた複合体の研
究も行われており、特開昭63−68155号ではポリ
乳酸にハイドロキシアパタイトを混合し、溶融押出によ
り成形したピン状成形物が開示されている。しかし、強
度の向上が図れないこと、また延伸すればポーラスな構
造となるなどの問題点がある。さらに加えて吸収性材料
の部分が分解吸収されるにつれてポーラスな構造にな
り、ある時点でより加速度的に分解吸収が促進される傾
向が不可避である。そのため、局部的にpHが上昇し、
炎症を起こす可能性が大きい。
Further, research on a composite using a bioabsorbable material has also been conducted, and Japanese Patent Laid-Open No. 63-68155 discloses a pin-shaped molded product obtained by mixing polylactic acid with hydroxyapatite and molding the mixture by melt extrusion. Has been done. However, there are problems that the strength cannot be improved and that the structure becomes porous when stretched. In addition, it is inevitable that a part of the absorptive material has a porous structure as it is decomposed and absorbed, and that the decomposition and absorption is accelerated more rapidly at a certain point. Therefore, the pH locally rises,
It is highly likely to cause irritation.

【0009】更に、USP4743257号において
は、生体吸収性高分子からなるマトリックスを同じ成分
からなるファイバーで補強する所謂self−rein
forceした複合体からなる骨接合材が示されている
が、これも繊維状にほぐれて表面積が大きくなるので、
ある時期に急激にバースト的吸収を起こす可能性が大き
く、それにより炎症を引き起こす場合が考えられる。
Further, in US Pat. No. 4,743,257, a so-called self-rein structure in which a matrix made of a bioabsorbable polymer is reinforced with fibers made of the same component.
An osteosynthesis material composed of a force-complexed composite material is shown, but this also loosens into a fibrous shape to increase the surface area.
It is highly possible that bursty absorption will occur at a certain time, which may cause inflammation.

【0010】本発明は上記のような問題点に鑑みてなさ
れたもので、初期強度、初期弾性率に優れ、生体内に埋
入後数ケ月程度で周囲のポリ乳酸の被覆部分が吸収さ
れ、その後はセラミックスの芯材が生体組織と適合する
ため、抜釘のための再手術の必要性がなく、また生体吸
収性のポリ乳酸の占める割合が低いため、吸収される絶
対量が少なく、炎症を引き起こす可能性が極めて低く、
新生骨により吸収された後の空洞が早期に埋まるという
理想的な骨接合用デバイスを提供することを目的とす
る。
The present invention has been made in view of the above problems, and is excellent in initial strength and initial elastic modulus, and the polylactic acid-coated portion around it is absorbed within a few months after implantation in a living body. After that, since the ceramic core material is compatible with living tissue, there is no need for re-operation for nail extraction, and since the proportion of bioabsorbable polylactic acid is low, the absolute amount absorbed is small and inflammation is reduced. Very unlikely to cause
It is an object of the present invention to provide an ideal osteosynthesis device in which the cavity after being absorbed by new bone is filled early.

【0011】[0011]

【課題を解決するための手段】上記目的を達成するた
め、本発明のデバイスはハイドロキシアパタイト(H
A)及びトリカルシウムホスフェイト(TCP)及びH
Aとウォラストナイトを含有する結晶化ガラスのそれぞ
れの単独物又はそれらの混合物を75〜95重量%含む
生分解性ポリマーの成形体を芯材とし、該芯材をポリ乳
酸で被覆したことを特徴とする。
In order to achieve the above object, the device of the present invention comprises a hydroxyapatite (H
A) and tricalcium phosphate (TCP) and H
A molded body of a biodegradable polymer containing 75 to 95% by weight of each crystallized glass containing A and wollastonite or a mixture thereof is used as a core material, and the core material is coated with polylactic acid. Characterize.

【0012】本発明に用いる芯材は、ハイドロキシアパ
タイト、トリカルシウムホスフェイト等の燐酸カルシウ
ム系セラミックスや、HA及びウォラストナイトを含有
する結晶化ガラス等の酸化物系セラミックスを主成分と
して用い、それにポリ乳酸やゼラチン、コラーゲン等の
生分解性ポリマーを加えて加熱、加圧成形することによ
り得られるものである。
The core material used in the present invention is mainly composed of calcium phosphate ceramics such as hydroxyapatite and tricalcium phosphate and oxide ceramics such as crystallized glass containing HA and wollastonite. It is obtained by adding a biodegradable polymer such as polylactic acid, gelatin or collagen, and heating and pressing.

【0013】前記ハイドロキシアパタイト、トリカルシ
ウムホスフェイト、HA及びウォラストナイトを含有す
る結晶化ガラスはそれらの粉末を単独又は混合して用
い、ポリ乳酸などの生分解性ポリマーを5〜25重量%
加えて、押出成形やプレス成形等の公知の成形手段で細
い棒状の芯材を造る。また、別の芯材の製法として、ポ
リマー成分を溶剤に溶かして上記粉末を加え、混合して
溶剤を除去する方法も採用できる。この場合、溶かすポ
リマー量は少量でよく、しかも分子量の高いものも使用
できるという利点がある。
For the crystallized glass containing hydroxyapatite, tricalcium phosphate, HA and wollastonite, powders thereof are used alone or in combination, and a biodegradable polymer such as polylactic acid is used in an amount of 5 to 25% by weight.
In addition, a thin rod-shaped core material is manufactured by a known molding means such as extrusion molding or press molding. Further, as another manufacturing method of the core material, a method of dissolving the polymer component in a solvent, adding the above-mentioned powder, mixing and removing the solvent can also be adopted. In this case, the amount of the polymer to be dissolved may be small, and there is an advantage that a polymer having a high molecular weight can be used.

【0014】本発明のデバイスにおいて、ハイドロキシ
アパタイト及びトリカルシウムホスフェイト及びHAと
ウォラストナイトを含有する結晶化ガラスのそれぞれの
単独又はそれらの混合物を75〜95重量%含む生分解
性ポリマーの成形物としたのは、上記セラミックスの成
分が75重量%以下ではセラミックスとしての物理的強
度があまり上がらないものとなり、また95重量%以上
ではポリマー成分が少なすぎて流動性及び成形性に問題
があるからである。このセラミックスの添加量は各成分
の粒径によっても左右されるものである。
In the device of the present invention, a molded article of biodegradable polymer containing 75 to 95% by weight of hydroxyapatite and tricalcium phosphate and 75 to 95% by weight of crystallized glass containing HA and wollastonite, respectively. The reason is that when the content of the above-mentioned ceramics is 75% by weight or less, the physical strength of the ceramics does not increase so much, and when it is 95% by weight or more, the polymer component is too small and there is a problem in fluidity and moldability. Is. The amount of this ceramic added depends on the particle size of each component.

【0015】一方、被覆材として使用する生体内吸収性
のポリ乳酸(以下、PLAと記す)は、光学活性を有す
るL体またはD体の乳酸から常法(C.E.Love,
米国特許第2668182号明細書)に従って乳酸の環
状二量体であるラクチドを合成したあと、そのラクチド
を開環重合することによって得られるもので、L体のポ
リ乳酸(以下、PLLAと記す)の方がより好適であ
る。このPLLAは、分子量と結晶化度を適度に調整す
ることが重要である。即ち、PLLAは分子量が高いも
のほど高強度の材料となるが、あまり分子量が高すぎる
と、溶融成形の際に高温、高圧が必要となるため大幅な
分子量低下を招き、結果として溶融成形後の分子量は低
いものとなり、当然のことながら強度も低いものとな
る。他方、結晶性材料は非晶性材料に比べて曲げ強度、
弾性率が高く、また体液の浸透は結晶相の方が遅く、見
掛け上の加水分解も遅い。しかし、熱処理により結晶化
度を上げていくと、強度は向上するが、PLLAが熱的
に不安定であるため劣化が進行して分子量低下が生じ、
加水分解速度が速くなり、強度劣化が急激に起こるよう
になる。このような理由から、被覆材料のPLLAは粘
度平均分子量が30万〜60万、なかんずく35万〜5
5万程度で、結晶化度が10〜60%程度のものが好適
に使用される。
On the other hand, the bioabsorbable polylactic acid (hereinafter referred to as PLA) used as the coating material is prepared from the optically active L- or D-form lactic acid by a conventional method (CE Love,
It is obtained by synthesizing a lactide which is a cyclic dimer of lactic acid according to U.S. Pat. No. 2,668,182) and then subjecting the lactide to ring-opening polymerization to obtain L-form polylactic acid (hereinafter referred to as PLLA). Is more preferable. It is important to adjust the molecular weight and crystallinity of this PLLA appropriately. That is, PLLA has a higher strength as the molecular weight is higher. However, if the molecular weight is too high, high temperature and high pressure are required in the melt molding, resulting in a large decrease in the molecular weight. The molecular weight is low, and naturally the strength is also low. On the other hand, crystalline materials have a higher bending strength than amorphous materials,
The elastic modulus is high, the penetration of body fluid is slower in the crystalline phase, and the apparent hydrolysis is slower. However, if the crystallinity is increased by heat treatment, the strength is improved, but the deterioration of the molecular weight is caused by the deterioration of PLLA due to thermal instability.
The hydrolysis rate becomes faster, and the strength deteriorates rapidly. For these reasons, the coating material PLLA has a viscosity average molecular weight of 300,000 to 600,000, and above all 350,000 to 5
Those having a crystallinity of about 50,000 and a crystallinity of about 10 to 60% are preferably used.

【0016】また、被覆材料のPLLAは、溶融成形後
に2〜5倍程度の延伸倍率で一軸延伸することが好まし
い。このように一軸延伸するとPLLA成形物の強度が
向上し、圧縮曲げ強度が160〜250MPa、圧縮曲
げ弾性率が5500〜24000MPaの値を示す強靱
なものとなり、また、延伸後の若干の戻りが生じること
によって芯材を締付ける力が大幅に増大するからであ
る。
Further, it is preferable that the coating material PLLA is uniaxially stretched at a stretching ratio of about 2 to 5 after the melt molding. When the uniaxially stretched as described above, the strength of the PLLA molded product is improved, the flexural strength becomes 160 to 250 MPa, and the flexural modulus of compression becomes 5500 to 24000 MPa. This significantly increases the force for tightening the core material.

【0017】上記の如き延伸又は無延伸のPLLA被覆
材で前記のセラミックスを主成分とする芯材を被覆した
本発明の骨接合用デバイスは、一般的な外科手術で用い
られているようなロッド、スクリュー、ピン等、種々の
形状で利用される。ロッドやピンの場合は芯材の直径を
1〜3.5mm(好ましくは1.2〜3mm)程度、P
LLA被覆材の厚みを0.75〜2mm(好ましくは1
〜1.5mm)程度、全体の直径を2.5〜8mm(好
ましくは3〜6mm)程度に設定したものが使用され、
またスクリューの場合もほぼ同寸法のものが使用される
が、スクリューのPLLA被覆材の厚みは溝切り分を考
慮してやや厚くするのが望ましい。
The osteosynthesis device of the present invention in which the core material containing ceramics as a main component is coated with the stretched or non-stretched PLLA coating material as described above is a rod used in general surgery. It is used in various shapes such as screws, screws, and pins. In the case of rods and pins, the diameter of the core material is about 1 to 3.5 mm (preferably 1.2 to 3 mm), P
The thickness of the LLA coating material is 0.75 to 2 mm (preferably 1
.About.1.5 mm), and an overall diameter set to about 2.5 to 8 mm (preferably 3 to 6 mm) is used.
Further, in the case of a screw, those having almost the same size are used, but it is desirable that the thickness of the PLLA coating material of the screw is slightly thicker in consideration of the groove cut portion.

【0018】本発明の骨接合用デバイスは、次のように
して製造される。一つの方法は、ハイドロキシアパタイ
ト等のセラミックス粉末にPLLAを混合し、芯材を成
形するための押出機を用い、その先端にクロスヘッドダ
イを取付け、芯材を押出すと同時に該ダイの側面からP
LLAのみを溶融押出し、ダイス内先端で上記芯材に被
覆する方法である。また、別の方法は、PLLAを溶融
成形し、一軸延伸した後、ドリル加工により孔をあけて
中空パイプとし、それを窒素雰囲気中、80℃前後で加
熱した状態で芯材を孔に挿入する方法である。この際、
ドリル加工で発生する熱がPLLAに蓄熱しないように
注意する必要がある。
The osteosynthesis device of the present invention is manufactured as follows. One method is to mix PLLA with ceramic powder such as hydroxyapatite and use an extruder for molding a core material, attach a crosshead die to the tip of the core material, and simultaneously extrude the core material from the side surface of the die. P
In this method, only LLA is melt extruded, and the core material is coated with the tip of the die. In another method, PLLA is melt-molded, uniaxially stretched, and then a hole is formed by drilling to form a hollow pipe, and the core material is inserted into the hole while being heated in a nitrogen atmosphere at about 80 ° C. Is the way. On this occasion,
It is necessary to take care so that the heat generated by drilling does not accumulate in the PLLA.

【0019】[0019]

【作用】本発明の骨接合用デバイスを体内に埋入する
と、表面のPLA(PLLA)が体液と接触して徐々に
加水分解を始め、表面から内側に穏やかに進行するが、
本発明のデバイスはPLAを被覆部分として使用し、芯
材の部分にはセラミックスのバインダー的な役目として
極めて少量のPLAを使用したものであるため、全体を
PLAで成形した従来のデバイスに比較すると、PLA
の吸収が早期に完了し、吸収される絶対量も少ない。従
って、本発明の骨接合用デバイスは炎症を起こす可能性
が極めて低い。そして、PLAの被覆材が完全に吸収さ
れた後には生体適合性に優れたハイドロキシアパタイト
等のセラミックスの芯材が残り、骨折部分や損傷部分が
完全に治癒するまでの間、骨接合用デバイスとしての機
能を果たす。
When the osteosynthesis device of the present invention is implanted in the body, PLA (PLLA) on the surface comes into contact with the body fluid and gradually starts to hydrolyze, and gently progresses from the surface to the inside.
In the device of the present invention, PLA is used as the coating portion, and a very small amount of PLA is used as the binder of the ceramic in the core material portion. , PLA
Absorption is completed early and the absolute amount absorbed is small. Therefore, the osteosynthesis device of the present invention is extremely unlikely to cause inflammation. After the PLA coating material is completely absorbed, the ceramic core material such as hydroxyapatite, which has excellent biocompatibility, remains, and as a device for osteosynthesis until the fracture or damaged portion is completely healed. Fulfill the function of.

【0020】このように本発明の骨接合用デバイスは、
PLA製デバイスに比べると、PLAの吸収速度が速
く、吸収される絶対量が少ないため、炎症を起こしにく
いものであり、しかもセラミックス成分が75〜95重
量%とセラミックスリッチの芯材をPLAで被覆してい
るため、従来のセラミックス製デバイスに見られるよう
な脆さの欠点を充分カバーできるものである。つまり、
初期強度がPLAと芯材の中間的な値を示し、その表面
特性はPLAの性質に依存する。PLAは有機ポリマー
としての靱性を与え、芯材は弾性率の高さと剛性が強い
ことの利点を与える。PLAにセラミックスを少量加え
たものは、本発明の芯材のような物理的強度の改善が見
られない。
As described above, the osteosynthesis device of the present invention is
Compared to PLA devices, PLA has a faster absorption rate and a smaller absolute amount of absorption, so it is less prone to inflammation, and PLA covers a ceramic-rich core material with a ceramic component of 75 to 95% by weight. Therefore, it is possible to sufficiently cover the defect of brittleness that is found in the conventional ceramic device. That is,
The initial strength shows an intermediate value between PLA and the core material, and its surface characteristics depend on the properties of PLA. PLA provides toughness as an organic polymer, and the core material provides the advantages of high elastic modulus and high rigidity. PLA added with a small amount of ceramics does not show improvement in physical strength as in the core material of the present invention.

【0021】また、被覆したPLAが完全に吸収された
時には、骨折及び損傷部位の治癒がある程度進行してお
り、セラミックス材料の欠点である周囲骨の強度低下の
現象も最小限に抑えることができる。更に、PLAに少
量のハイドロキシアパタイトを粉末で混合したり、或は
フレーク状で混合したり、繊維補強したものと比較して
も、バースト的な吸収がなく、炎症を起こす可能性が低
いなど、現在使用或は検討されている骨接合デバイスに
比べても極めて優れた骨接合用デバイスであると言え
る。
Further, when the coated PLA is completely absorbed, the healing of the fracture and the damaged site has progressed to some extent, and the phenomenon of the strength decrease of the surrounding bone, which is a defect of the ceramic material, can be minimized. .. In addition, PLA is mixed with a small amount of hydroxyapatite in powder form, or is mixed in the form of flakes, or even when compared with fiber reinforced ones, there is no burst absorption and there is less possibility of causing inflammation. It can be said that it is an extremely excellent osteosynthesis device as compared with the osteosynthesis devices currently used or studied.

【0022】また、本発明者らは、被覆材として好適に
使用されるPLAを延伸すると圧電性を生じるという事
実を見出した。この圧電性の効果により仮骨の生成が促
進されることが判っており、その点からも本発明の骨接
合用デバイスは理想的なものと言える。
The present inventors have also found out that stretching PLA, which is preferably used as a covering material, causes piezoelectricity. It has been known that the generation of callus is promoted by this piezoelectric effect, and from this point, it can be said that the osteosynthesis device of the present invention is ideal.

【0023】更に、PLAからなる従来のデバイスはX
線によるレントゲン撮影には写らないという欠点があ
り、埋入後の分解挙動などを把握しにくいという問題が
あったが、本発明の骨接合用デバイスは、芯材として用
いるセラミックス系成形物がX線撮影可能であり、レン
トゲン撮影時のマーカーにもなる得る。
In addition, the conventional device consisting of PLA is X
Although there is a problem that it is difficult to grasp the decomposition behavior after embedding and the like because the X-ray imaging with a line does not appear, it is difficult to grasp the decomposition behavior after implantation. However, in the osteosynthesis device of the present invention, the ceramic-based molding used as the core material is X-ray. It can be used for X-ray photography and can also serve as a marker during X-ray photography.

【0024】[0024]

【実施例】以下、本発明の実施例を詳述する。EXAMPLES Examples of the present invention will be described in detail below.

【0025】ハイドロキシアパタイト(HA)の粉末
と、粘度平均分子量(クロロホルム中25℃で測定)が
40万のPLLAとを80:20の重量比率で混合し、
溶融押出により製造された直径1.5mmの成形物を所
定の長さに切断して芯材を得た。他方、前述の分子量4
0万のPLLAを棒状体に溶融押出し、その後4倍に延
伸して所定の寸法に切断し、長軸方向にドリルで孔開け
加工を施して外径3.2mm、長さ5cmのロッドを作
製した。そして、窒素雰囲気中80℃前後で該ロッドに
上記芯材を挿入し、複合ロッドを作製した(サンプル
1)。
Hydroxyapatite (HA) powder was mixed with PLLA having a viscosity average molecular weight (measured in chloroform at 25 ° C.) of 400,000 at a weight ratio of 80:20,
A molded product having a diameter of 1.5 mm manufactured by melt extrusion was cut into a predetermined length to obtain a core material. On the other hand, the above-mentioned molecular weight 4
Melting and extruding 0,000 PLLA into a rod, then stretching it 4 times, cutting it to a predetermined size, and drilling in the long axis direction with a drill to make a rod with an outer diameter of 3.2 mm and a length of 5 cm. did. Then, the core material was inserted into the rod at about 80 ° C. in a nitrogen atmosphere to prepare a composite rod (Sample 1).

【0026】同様の方法で、トリカルシウムホスフェイ
トの粉末とPLLAとを80:20の重量比率で混合し
た芯材を造り、PLLAを上記と同様に被せて複合ロッ
ドを作製した。このロッドの芯材の直径は2mm、PL
LAを被覆後の外径は6.5mm、長さは5cmであっ
た。これを切削加工して海綿骨用スクリュー(スクリュ
ーの谷径は4mm、PLLAの肉厚は谷径の部分で1m
m、山径の部分で2.25mm)を作製した(サンプル
2)。
In the same manner, a core material was prepared by mixing tricalcium phosphate powder and PLLA in a weight ratio of 80:20, and PLLA was covered in the same manner as above to prepare a composite rod. The diameter of the core of this rod is 2mm, PL
The outer diameter after coating LA was 6.5 mm, and the length was 5 cm. This is cut and processed for cancellous bone screw (screw root diameter is 4 mm, PLLA wall thickness is 1 m at the root diameter part)
m, 2.25 mm in the portion of the mountain diameter) was produced (Sample 2).

【0027】また、同様にアルミナウォレストナイトの
粉末とPLLAとを80:20の重量比率で混合した芯
材を造り、PLLAを上記と同様に被せて複合ロッドを
作製した。このロッドの芯材の直径は2mm、PLLA
を被覆後の外径は6.5mm、長さは5cmであった。
これに切削加工を施してサンプル2と同径、同長のスク
リューを作製した(サンプル3)。
Similarly, a core material was prepared by mixing alumina wollastonite powder and PLLA in a weight ratio of 80:20, and PLLA was covered in the same manner as above to prepare a composite rod. The diameter of the core material of this rod is 2 mm, PLLA
The outer diameter after coating was 6.5 mm and the length was 5 cm.
By cutting this, a screw having the same diameter and the same length as the sample 2 was produced (sample 3).

【0028】更に、ハイドロキシアパタイト、トリカル
シウムホスフェイト、アルミナウォラストナイトを等量
ずつ混合し、それに20重量%のPLLAを加えて、こ
れを芯材用の押出機に投入し、被覆用の押出機にはPL
LAを投入してクロスヘッドダイを用いて芯材の直径が
約2mm、被覆材の厚みが約4mmの複合ロッドを作製
した(サンプル4)。
Further, hydroxyapatite, tricalcium phosphate and alumina wollastonite are mixed in equal amounts, 20% by weight of PLLA is added thereto, and this is put into an extruder for core material and extruded for coating. PL in the machine
LA was introduced and a crosshead die was used to prepare a composite rod having a core material diameter of about 2 mm and a coating material thickness of about 4 mm (Sample 4).

【0029】これらの物理的強度を測定したところ、曲
げ強度及び曲げ弾性率は芯材が支配的であり、実測値の
平均は以下の通りであった。 曲げ強度(kg/cm2 ) 曲げ弾性率(kg/mm2 ) サンプル1 2800 2500 サンプル2 2400 2300 サンプル3 2450 2300 サンプル4 2500 2200
When the physical strengths of these materials were measured, the bending strength and bending elastic modulus were dominated by the core material, and the average measured values were as follows. Flexural strength (kg / cm2) Flexural modulus (kg / mm2) Sample 1 2800 2500 Sample 2 2400 2300 Sample 3 2450 2300 Sample 4 2500 2200

【0030】また、表面はPLLAの物性に依存し、セ
ラミックスの脆さはなく、靱性を有していた。しかも、
PLLAのような可撓性はなく、芯材の剛性を有してい
るので、スクリューを埋入するのに都合のよい強度を有
していた。
The surface depended on the physical properties of PLLA, and the ceramic had no brittleness and had toughness. Moreover,
It was not as flexible as PLLA and had the rigidity of the core material, so it had a strength suitable for embedding a screw.

【0031】次に、5羽の家兎の頸骨近位部に実験的に
骨切り術を行い、サンプル2及びサンプル3のスクリュ
ーを用いて内固定した。即ち、体重3kgの家兎の右頸
骨近位部に間接面約1/3を含む縦割れ骨折を作成し、
スクリュー1本にて固定した。外固定はせずケージレス
トにて行った。コントロールとしてPLLAのみからな
る同径のスクリューを用いて同様の整復、固定を行っ
た。
Next, an osteotomy was experimentally performed on the tibia proximal parts of five rabbits, and internally fixed using the screws of Sample 2 and Sample 3. That is, a longitudinal fracture containing a joint surface of about 1/3 is made in the proximal portion of the right tibia of a rabbit weighing 3 kg,
It was fixed with one screw. It was performed at the cage rest without external fixation. As a control, the same reduction and fixation were performed using a screw of the same diameter made of only PLLA.

【0032】25ケ月経過後、各々を屠殺してスクリュ
ー孔を観察したところ、コントロールのスクリューは約
5〜30%のPLLAが残存しており、その分子量は2
000〜3000程度に低下していた。また、スクリュ
ー孔が明瞭に認められ、新生骨によって完全に置換され
るまでには至っていなかった。サンプル2のスクリュー
の場合、表面のPLLAは分解、吸収されて消滅してお
り、その部分は新生骨により置換されていた。また、芯
の部分については、PLLAが分解吸収されるにつれて
ポーラスな構造となり、体液との接触面積が増大するた
め、コントロールよりも早期に分解吸収される傾向があ
った。その結果、芯部分のPLLAの残存はわずかに認
められたが、ほぼ新生骨に置換されていた。
After 25 months, each was slaughtered and the screw holes were observed. As a result, about 5 to 30% of PLLA remained in the control screw, and its molecular weight was 2%.
000 to 3,000. In addition, the screw hole was clearly recognized, and it was not completely replaced by the new bone. In the case of the screw of sample 2, the PLLA on the surface was decomposed, absorbed, and disappeared, and the part was replaced by new bone. Further, the core portion has a porous structure as the PLLA is decomposed and absorbed, and the contact area with the body fluid increases, so that it tends to be decomposed and absorbed earlier than the control. As a result, although a small amount of PLLA remained in the core part, it was almost replaced with new bone.

【0033】また、サンプル3のスクリューもサンプル
2のスクリューの場合と同様に表面のPLLAは分解吸
収されており、その部分は新生骨によりほぼ置換されて
いた。また、芯材の部分もPLLAの残存は認められた
が、コントロールの場合の残存量に比べると遥かに少量
であり、PLLAが吸収された部分は新生骨でほぼ完全
に置換されていた。
As in the case of the screw of Sample 2, the screw of Sample 3 had the surface PLLA decomposed and absorbed, and that portion was almost replaced by the new bone. Although the residual amount of PLLA was also recognized in the core material, the amount was much smaller than the residual amount in the case of the control, and the portion in which PLLA was absorbed was almost completely replaced by the new bone.

【0034】[0034]

【発明の効果】以上の説明から明らかなように、本発明
の骨接合用デバイスは、PLA(PLLA)のみからな
るデバイスに比べるとPLA(PLLA)の総量が少な
いため分解吸収は短期間で完了し、吸収される絶対量も
少ないため炎症を起こしたりする恐れも極めて低い。従
って、限定された局所部に複数本のデバイスを使用でき
る利点もある。そして、この分解吸収過程とその終焉時
期に新生骨が空洞部分に薄く橋渡しした状態となって埋
まる状態となりやすいので、全てが吸収性材料である場
合に新生骨が完全に埋まる2〜3年或は3〜4年の長期
を要せず、短期間に新生骨で埋まるという利点を有す
る。
As is apparent from the above description, the osteosynthesis device of the present invention has a smaller total amount of PLA (PLLA) than a device composed of only PLA (PLLA), and therefore decomposition and absorption can be completed in a short period of time. However, since the absolute amount absorbed is also small, the risk of causing inflammation is extremely low. Therefore, there is also an advantage that a plurality of devices can be used in a limited local area. Then, during this decomposition and absorption process and its final stage, the new bone is apt to be buried in a state that it is thinly bridged to the hollow portion, so if the whole is an absorbable material, the new bone is completely buried for 2-3 years or Has the advantage of filling with new bone in a short period of time without requiring a long period of 3 to 4 years.

【0035】また、被覆材料のPLAが完全に分解吸収
された後は、生体適合性に優れたセラミックスを含む芯
材が、骨折及び損傷部位が完全に治癒するまでの間、骨
接合用デバイスとしての機能を果たす。そして、PLA
の被覆材等が完全に吸収された時には、新生骨の発生に
より骨折及び損傷部位の治癒がある程度進行しており、
セラミックス系デバイスの欠点である周囲骨の強度低下
の現象を最小限に抑えることができるという効果もあ
る。
Further, after the PLA of the coating material is completely decomposed and absorbed, the core material containing ceramics having excellent biocompatibility is used as an osteosynthesis device until the fracture and the damaged site are completely healed. Fulfill the function of. And PLA
When the covering material etc. of is completely absorbed, the healing of the fracture and damaged site has progressed to some extent due to the generation of new bone,
There is also an effect that it is possible to minimize the phenomenon of strength deterioration of the surrounding bone, which is a drawback of the ceramic-based device.

【0036】更に、セラミックスを含む芯材がレントゲ
ン撮影時のマーカーになるので、PLAのみからなるデ
バイスがレントゲン撮影で写らないという欠点も解消で
きる。そして、被覆材料として延伸したPLAを用いた
場合には、圧電効果により仮骨の生成が促進されるとい
う効果もあり、新生骨発生による治癒の促進が見られる
ものである。
Further, since the core material containing ceramics serves as a marker during radiography, it is possible to eliminate the drawback that a device consisting of PLA is not captured during radiography. When the stretched PLA is used as the coating material, there is also an effect that the generation of callus is promoted by the piezoelectric effect, and the promotion of healing due to the generation of new bone can be seen.

【0037】このように、本発明の骨接合用デバイスは
極めて理想的なものである。
As described above, the osteosynthesis device of the present invention is extremely ideal.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】ハイドロキシアパタイト(HA)及びトリ
カルシウムホスフェイト(TCP)及びHAとウォラス
トナイトを含有する結晶化ガラスのそれぞれの単独物又
はそれらの混合物を75〜95重量%含む生分解性ポリ
マーの成形体を芯材とし、該芯材をポリ乳酸で被覆した
ことを特徴とする骨接合用デバイス。
1. A biodegradable polymer containing 75 to 95% by weight of hydroxyapatite (HA) and tricalcium phosphate (TCP) and crystallized glass containing HA and wollastonite alone or in a mixture thereof. A bone-bonding device, characterized in that the molded body of 1. is used as a core material, and the core material is coated with polylactic acid.
【請求項2】ポリ乳酸が一軸延伸されていることを特徴
とする請求項1に記載の骨接合用デバイス。
2. The osteosynthesis device according to claim 1, wherein polylactic acid is uniaxially stretched.
JP4079003A 1992-02-28 1992-02-28 Osteosynthesis device Expired - Fee Related JP3010279B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4079003A JP3010279B2 (en) 1992-02-28 1992-02-28 Osteosynthesis device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4079003A JP3010279B2 (en) 1992-02-28 1992-02-28 Osteosynthesis device

Publications (2)

Publication Number Publication Date
JPH05237180A true JPH05237180A (en) 1993-09-17
JP3010279B2 JP3010279B2 (en) 2000-02-21

Family

ID=13677785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4079003A Expired - Fee Related JP3010279B2 (en) 1992-02-28 1992-02-28 Osteosynthesis device

Country Status (1)

Country Link
JP (1) JP3010279B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203574B1 (en) 1998-04-14 2001-03-20 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone filler and process for the production of the same
JP2012505723A (en) * 2008-10-15 2012-03-08 スミス アンド ネフュー インコーポレーテッド Composite in-house fixator
WO2020029502A1 (en) * 2018-08-07 2020-02-13 宁波宝亭生物科技有限公司 Absorbable bone fixation device and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203574B1 (en) 1998-04-14 2001-03-20 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone filler and process for the production of the same
JP2012505723A (en) * 2008-10-15 2012-03-08 スミス アンド ネフュー インコーポレーテッド Composite in-house fixator
US9492210B2 (en) 2008-10-15 2016-11-15 Smith & Nephew, Inc. Composite internal fixators
WO2020029502A1 (en) * 2018-08-07 2020-02-13 宁波宝亭生物科技有限公司 Absorbable bone fixation device and preparation method thereof

Also Published As

Publication number Publication date
JP3010279B2 (en) 2000-02-21

Similar Documents

Publication Publication Date Title
JP2860663B2 (en) Biodegradable and absorbable surgical molding
EP0854734B1 (en) Under tissue conditions degradable material and a method for its manufacturing
Rokkanen Absorbable materials in orthopaedic surgery
FI81498B (en) SURGICAL MATERIAL OCH INSTRUMENT.
Bessho et al. A bioabsorbable poly-L-lactide miniplate and screw system for osteosynthesis in oral and maxillofacial surgery
Törmälä Biodegradable self-reinforced composite materials; manufacturing structure and mechanical properties
JPS6368155A (en) Bone bonding pin
FI120963B (en) Bioabsorbable elongated organ
US20090149856A1 (en) Medical device and its manufacture
EP0323993B1 (en) Absorbable material for fixation of tissues
JP2002505142A (en) Biocompatible deformable fixation plate
JP2587664B2 (en) Biodegradable and absorbable surgical materials
Majola et al. Intramedullary fixation of cortical bone osteotomies with self-reinforced polylactic rods in rabbits
Törmälä Ultra-high strength, self-reinforced absorbable polymeric composites for applications in different disciplines of surgery
JP2003521973A (en) Bioabsorbable bone promoting fixation plate
JP3010279B2 (en) Osteosynthesis device
JP3074410B2 (en) Osteosynthesis device
JP3243685B2 (en) Implant material and method for producing the same
JPH06142182A (en) Internal fixing material for joining bone
CN104623742A (en) Bioactive absorbable medical strapping tape and forming method
WO2020029502A1 (en) Absorbable bone fixation device and preparation method thereof
JP3023470B2 (en) Method for producing osteosynthesis material having through holes
JP3141088B2 (en) Method for producing biodegradable and absorbable surgical materials
Gutwald et al. Is there a need for resorbable implants or bone substitutes?
KR20060036395A (en) Biodegradable implant and method for manufacturing one

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19991012

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071210

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081210

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081210

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091210

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091210

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091210

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101210

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101210

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111210

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111210

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees